Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional), a US federal funding opportunity from National Institutes of Health (opportunity number RFA-DC-26-001). See the official Grants.gov listing for eligibility, award amounts, and application instructions.